Key statistics
As of last trade United Therapeutics Corp (UTH:MUN) traded at 424.55, -6.59% below its 52-week high of 454.50, set on Feb 26, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 424.55 |
|---|---|
| High | 424.55 |
| Low | 424.55 |
| Bid | 434.65 |
| Offer | 435.55 |
| Previous close | 427.25 |
| Average volume | 74.00 |
|---|---|
| Shares outstanding | 43.83m |
| Free float | 42.98m |
| P/E (TTM) | 18.06 |
| Market cap | 22.08bn USD |
| EPS (TTM) | 27.90 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:04 GMT.
More ▼
- United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
- United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
- United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
- United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
